Skip to main content

MARSHALL WACE, LLP

Position in ABT — Abbott Laboratories

CIK 1318757 LONDON, X0

Position in ABT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$502,920,823
+$296,457,820 QoQ
Shares Held
5,542,438
+175.6% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#41
of 2,958 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Jun 30, 2026
CallValue
$145,184
CallShares
1,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. ABT ranks #1 (52.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
This page
5,542,438 $502,920,823

All Filings in ABT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $502,920,823 5,542,438
2026-06-30 $145,184 1,600
2026-03-31 $206,463,003 2,010,938
2025-12-31 $12,529 100
2025-12-31 $7,327,836 58,487
2025-03-31 $20,817,427 156,935
2024-12-31 $33,933,000 300,000
2024-09-30 $14,049,110 123,227
2024-06-30 $22,479,577 216,337
2024-03-31 $90,928 800
2024-03-31 $2,500,520 22,000
2023-12-31 $15,359,497 139,543
2023-12-31 $22,102,056 200,800
2023-12-31 $15,684,975 142,500
2023-09-30 $3,297,548 34,048
2023-06-30 $27,126,029 248,817
2023-03-31 $395,420 3,905
2022-06-30 $3,443,987 31,698
2022-03-31 $67,496,683 570,266
2021-12-31 $176,035,480 1,250,785
2021-09-30 $29,006,939 245,551
2021-06-30 $31,839,942 274,648
2021-03-31 $19,411,084 161,975
2020-09-30 $4,856,538 44,625
2020-06-30 $8,518,167 93,166